Log In
Print
BCIQ
Print
Print this Print this
 

Vasomera (PB1046)

  Manage Alerts
Collapse Summary General Information
Company PhaseBio Pharmaceuticals Inc.
DescriptionVasoactive intestinal peptide receptor 2 (VPAC2) agonist
Molecular Target Vasoactive intestinal peptide receptor 2 (VPAC2)
Mechanism of ActionVasoactive intestinal peptide receptor 2 (VPAC2) agonist
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today